Related Experiment Video
Updated: Oct 2, 2025
Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
Published on: June 14, 2024
Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours
Lydia G White1, Hannah E Goy1, Alinor J Rose1,2
1Department of Microbiology and Immunology, University of Otago, Dunedin 9016, New Zealand.
Abstract:
The precision guiding of endogenous or adoptively transferred lymphocytes to the solid tumour mass is obligatory for optimal anti-tumour effects and will improve patient safety. The recognition and elimination of the tumour is best achieved when anti-tumour lymphocytes are proximal to the malignant cells. For example, the regional secretion of soluble factors, cytotoxic granules, and cell-surface molecule interactions are required for the death of tumour cells and the suppression of neovasculature formation, tumour-associated suppressor, or stromal cells. The resistance of individual tumour cell clones to cellular therapy and the hostile environment of the solid tumours is a major challenge to adoptive cell therapy. We review the strategies that could be useful to overcoming insufficient immune cell migration to the tumour cell mass. We argue that existing 'competitive' approaches should now be revisited as complementary approaches to improve CAR T and NK cell therapy.
Insights
Guiding lymphocytes to solid tumors is crucial for effective cancer treatment and patient safety. Revisiting competitive strategies as complementary approaches can enhance CAR T and NK cell therapy for better tumor cell elimination.
Area of Science:
- Immunology
- Oncology
- Cell Therapy
Background:
- Optimal anti-tumour effects require precise homing of lymphocytes to solid tumours.
- Tumour recognition and elimination depend on lymphocyte proximity to malignant cells.
- Solid tumours present challenges to adoptive cell therapy due to resistant clones and hostile environments.
Purpose of the Study:
- To review strategies for overcoming insufficient immune cell migration to solid tumours.
- To explore methods for improving the efficacy of adoptive cell therapy.
- To propose a complementary approach to enhance CAR T and NK cell therapy.
Main Methods:
- Review of existing literature on immune cell migration and adoptive cell therapy.
- Analysis of strategies to enhance lymphocyte homing to tumour sites.
- Evaluation of 'competitive' approaches in the context of CAR T and NK cell therapy.
Main Results:
- Insufficient immune cell migration to tumours is a significant hurdle in adoptive cell therapy.
- Strategies exist to improve lymphocyte trafficking to solid tumour masses.
- Revisiting 'competitive' strategies as complementary approaches shows promise.
Conclusions:
- Enhancing lymphocyte homing to solid tumours is essential for effective cancer immunotherapy.
- Complementary strategies can overcome limitations of current adoptive cell therapy.
- Improved CAR T and NK cell therapy may be achieved by integrating revisited competitive approaches.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...